Chimerix ROA 2011-2020 | CMRX

Current and historical return on assets (ROA) values for Chimerix (CMRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Chimerix ROA for the three months ending March 31, 2020 was -31.11%.
Chimerix ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-03-31 $-0.11B $0.11B -81.85%
2019-12-31 $-0.11B $0.12B -77.55%
2019-09-30 $-0.13B $0.13B -75.76%
2019-06-30 $-0.07B $0.16B -36.66%
2019-03-31 $-0.07B $0.18B -35.37%
2018-12-31 $-0.07B $0.19B -34.74%
2018-09-30 $-0.07B $0.20B -34.82%
2018-06-30 $-0.08B $0.20B -33.44%
2018-03-31 $-0.07B $0.22B -30.61%
2017-12-31 $-0.07B $0.24B -28.09%
2017-09-30 $-0.07B $0.25B -25.21%
2017-06-30 $-0.07B $0.26B -24.06%
2017-03-31 $-0.07B $0.27B -23.31%
2016-12-31 $-0.08B $0.29B -24.94%
2016-09-30 $-0.10B $0.30B -30.75%
2016-06-30 $-0.11B $0.31B -32.97%
2016-03-31 $-0.12B $0.32B -32.40%
2015-12-31 $-0.12B $0.36B -32.41%
2015-09-30 $-0.10B $0.39B -28.70%
2015-06-30 $-0.08B $0.42B -28.43%
2015-03-31 $-0.07B $0.27B -29.43%
2014-12-31 $-0.06B $0.29B -29.76%
2014-09-30 $-0.05B $0.19B -30.62%
2014-06-30 $-0.04B $0.21B -27.41%
2014-03-31 $-0.05B $0.10B -39.83%
2013-12-31 $-0.07B $0.11B -73.58%
2013-09-30 $-0.07B $0.12B -87.87%
2013-06-30 $-0.05B $0.13B -116.76%
2013-03-31 $-0.04B $0.03B -262.07%
2012-12-31 $-0.01B $0.03B -137.50%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.186B $0.013B
Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $167.722B 29.09
Medtronic (MDT) Ireland $126.954B 20.62
Stryker (SYK) United States $68.485B 22.23
Boston Scientific (BSX) United States $49.285B 23.17
Baxter (BAX) United States $42.935B 26.21
Lonza Group Ag (LZAGY) Switzerland $42.808B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.540B 0.00
Terumo (TRUMY) Japan $28.459B 36.38
ResMed (RMD) United States $28.216B 44.53
Zimmer Biomet Holdings (ZBH) United States $25.629B 16.13
Sunny Optical Technology (SNPTF) China $19.798B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.231B 0.00
Bio-Rad Laboratories (BIO) United States $14.496B 65.99
Insulet (PODD) United States $12.375B 1226.06
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.034B 0.00
Quidel (QDEL) United States $10.072B 79.15
Perrigo (PRGO) Ireland $7.668B 13.72
GN STORE NORD (GNNDY) Denmark $7.593B 38.70
Hill-Rom Holdings (HRC) United States $7.275B 20.51
William Demant Holdings (WILYY) Denmark $6.812B 0.00
Canopy Growth (CGC) Canada $6.098B 0.00
Haemonetics (HAE) United States $4.423B 26.57
GW Pharmaceuticals (GWPH) United Kingdom $4.332B 0.00
Neogen (NEOG) United States $4.111B 69.63
ICU Medical (ICUI) United States $3.822B 27.88
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.815B 0.00
Abcam (ABCZY) $3.538B 0.00
Agios Pharmaceuticals (AGIO) United States $3.500B 0.00
Envista Holdings (NVST) United States $3.317B 0.00
NuVasive (NUVA) United States $2.878B 23.11
TG Therapeutics (TGTX) United States $2.498B 0.00
National Vision Holdings (EYE) United States $2.320B 40.14
AtriCure (ATRC) United States $1.784B 0.00
MacroGenics (MGNX) United States $1.393B 0.00
Aphria (APHA) Canada $1.356B 0.00
Aurora Cannabis (ACB) Canada $1.331B 0.00
NanoString Technologies (NSTG) United States $1.275B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.124B 146.15
Cerus (CERS) United States $1.095B 0.00
Vapotherm (VAPO) United States $1.044B 0.00
Phibro Animal Health (PAHC) United States $1.044B 20.81
InMode (INMD) Israel $1.035B 21.86
Meridian Bioscience (VIVO) United States $1.006B 37.89
PetIQ (PETQ) United States $0.984B 28.41
Cardiovascular Systems (CSII) United States $0.983B 0.00
Zynex (ZYXI) United States $0.870B 87.40
OraSure Technologies (OSUR) United States $0.870B 175.13
Quanterix (QTRX) United States $0.780B 0.00
Omeros (OMER) United States $0.737B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.664B 47.58
BioLife Solutions (BLFS) United States $0.614B 174.73
VAREX IMAGING (VREX) United States $0.601B 14.93
Lantheus Holdings (LNTH) United States $0.596B 11.99
Surmodics (SRDX) United States $0.592B 71.36
LeMaitre Vascular (LMAT) United States $0.535B 30.47
Owens & Minor (OMI) United States $0.483B 12.77
Viemed Healthcare (VMD) United States $0.400B 35.52
Cytosorbents (CTSO) United States $0.366B 0.00
HEXO (HEXO) $0.324B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.312B 0.00
Utah Medical Products (UTMD) United States $0.307B 22.30
Organigram Holdings (OGI) Canada $0.267B 0.00
InfuSystems Holdings (INFU) United States $0.223B 123.33
Female Health (VERU) United States $0.201B 0.00
Bovie Medical (APYX) United States $0.168B 0.00
Surface Oncology (SURF) United States $0.147B 0.00
Fonar (FONR) United States $0.139B 12.32
Exagen (XGN) United States $0.137B 0.00
Wound Management Technologies (SMTI) United States $0.136B 0.00
Liberty Health Sciences (LHSIF) Canada $0.123B 0.00
Rockwell Medical (RMTI) United States $0.121B 0.00
Chembio Diagnostics (CEMI) United States $0.110B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.108B 0.00
Evolus (EOLS) United States $0.106B 0.00
MTech Acquisition (KERN) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Nephros (NEPH) United States $0.067B 0.00
United-Guardian (UG) United States $0.065B 14.98
Brainsway (BWAY) Israel $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 0.00
Capricor Therapeutics (CAPR) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00